HKD 26.55
(-1.12%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.51 Billion | 5.54 Billion | 3.92 Billion | -7.38 Billion | 2.85 Billion | 1.03 Billion |
Net Income | 1.59 Billion | 1.17 Billion | 1.3 Billion | 1.15 Billion | 1.7 Billion | 1.91 Billion |
Depreciation & Amortization | 357.19 Million | 390.86 Million | 405.8 Million | 393.96 Million | 373.53 Million | 177.63 Million |
Deferred income taxes | - | -781.96 Million | -812.09 Million | -788.75 Million | -748.46 Million | -356.68 Million |
Stock-based compensation | 14.26 Million | 239 Thousand | 480 Thousand | 820 Thousand | 1.4 Million | 1.42 Million |
Change in working capital | 22.93 Million | 1.76 Billion | 1.05 Billion | -9.39 Billion | 491.13 Million | -1.88 Billion |
Other non-cash items | 1.26 Billion | 3 Billion | 1.96 Billion | 1.24 Billion | 1.03 Billion | 1.18 Billion |
Investing Cash Flow | -13.93 Billion | -690.75 Million | -9.07 Billion | -5.45 Billion | -8.86 Billion | -18.87 Billion |
Investments in PPE | -281.07 Million | -184.82 Million | -240.24 Million | -139.87 Million | -105.65 Million | -176.23 Million |
Acquisitions | 17.81 Million | 214 Thousand | 229 Thousand | 136 Thousand | 947 Thousand | 134 Thousand |
Investment purchases | -8.22 Billion | -12.27 Billion | -4.11 Billion | -8.13 Billion | -6.46 Billion | -11 Billion |
Sales/Maturities of investments | 1.07 Billion | 3.39 Billion | 2.47 Billion | 3.84 Billion | 4.73 Billion | 2.28 Billion |
Other Investing Activities | -44.88 Million | 8.36 Billion | -7.19 Billion | -1.02 Billion | -7.03 Billion | -9.97 Billion |
Financing Cash Flow | 5.8 Billion | 3.11 Billion | 1.41 Billion | 7.68 Billion | 7.15 Billion | 12.19 Billion |
Debt repayment | -312.34 Million | -2.4 Billion | -1.42 Billion | -711.35 Million | -1.34 Billion | -1.52 Billion |
Dividends payments | -373.19 Million | -338.75 Million | -319.57 Million | -431.42 Million | -472.97 Million | -472.45 Million |
Common Stock Repurchased | - | - | - | - | -591.63 Million | - |
Common Stock Issuance | - | - | - | - | 9.74 Billion | - |
Other Financing Activities | -144.11 Million | 5.86 Billion | 3.15 Billion | 8.82 Billion | -172.94 Million | 14.18 Billion |
Accounts receivables | 775.23 Million | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -7.75 Billion | 1.76 Billion | 1.05 Billion | -9.39 Billion | 491.13 Million | -9.98 Billion |
Cash at beginning of period | 21.42 Billion | 16.84 Billion | 19.93 Billion | 26.06 Billion | 16.47 Billion | 22.57 Billion |
Cash at end of period | 20.25 Billion | 21.42 Billion | 16.84 Billion | 19.93 Billion | 26.06 Billion | 16.47 Billion |
Capital Expenditure | -281.07 Million | -184.82 Million | -240.24 Million | -139.87 Million | -105.65 Million | -176.23 Million |
Effect of forex changes on cash | 5.99 Million | -290.9 Million | -13.91 Million | 181.47 Million | -32.85 Million | -133.99 Million |
Net cash flow / Change in cash | -1.17 Billion | 4.57 Billion | -3.08 Billion | -6.13 Billion | 9.58 Billion | -6.09 Billion |
Free Cash Flow | 2.23 Billion | 5.35 Billion | 3.68 Billion | -7.52 Billion | 2.75 Billion | 861.3 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.11 Billion | 670.23 Million | 1.59 Billion | 921.86 Million | 1.17 Billion | 338.39 Million |
Depreciation & Amortization | 191.25 Million | 183.26 Million | 357.19 Million | 174.99 Million | 390.86 Million | 209.04 Million |
Deferred income taxes | - | - | - | -360.3 Million | -781.96 Million | -418.18 Million |
Stock-based compensation | - | 3.93 Million | 53 Thousand | 10.32 Million | 239 Thousand | 86 Thousand |
Change in working capital | 3.01 Billion | -5.81 Billion | 22.93 Million | -826.31 Million | 1.76 Billion | 916.14 Million |
Other non-cash items | -4.1 Billion | -1.34 Billion | 1.26 Billion | 145.94 Million | 3 Billion | 1.37 Billion |
Investing Cash Flow | -141.1 Million | -6.28 Million | -13.93 Billion | -4.55 Billion | -690.75 Million | -1.51 Billion |
Investments in PPE | -141.14 Million | 40.08 Million | -281.07 Million | -40.08 Million | -184.82 Million | 34.97 Million |
Acquisitions | 36 Thousand | 16.32 Million | 17.81 Million | 1.49 Million | 214 Thousand | 139 Thousand |
Investment purchases | -4.92 Billion | -5.12 Billion | -8.22 Billion | -3.09 Billion | -12.27 Billion | -4.33 Billion |
Sales/Maturities of investments | 1.75 Billion | 249.32 Million | 1.07 Billion | 825.72 Million | 3.39 Billion | 1.88 Billion |
Other Investing Activities | 36 Thousand | -46.37 Million | -44.88 Million | 1.49 Million | 8.36 Billion | -38.67 Million |
Financing Cash Flow | -155.24 Million | 7.39 Billion | 5.8 Billion | -1.74 Billion | 3.11 Billion | -643.85 Million |
Debt repayment | -1.83 Billion | -913.94 Million | -312.34 Million | -2.54 Billion | -2.4 Billion | -1.28 Billion |
Dividends payments | -522.68 Million | -114.65 Million | -373.19 Million | -258.53 Million | -338.75 Million | -105.46 Million |
Common Stock Repurchased | -3.5 Million | 18.49 Million | - | -18.49 Million | - | - |
Common Stock Issuance | - | - | - | 1.17 Billion | - | - |
Other Financing Activities | 2.2 Billion | 7.5 Billion | -144.11 Million | -104.48 Million | 5.86 Billion | -36.02 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 3.01 Billion | -5.81 Billion | -7.75 Billion | -1.94 Billion | 1.76 Billion | -7.68 Billion |
Cash at beginning of period | 20.25 Billion | 20.26 Billion | 21.42 Billion | 26.61 Billion | 16.84 Billion | 21.73 Billion |
Cash at end of period | 20.15 Billion | 20.26 Billion | 20.25 Billion | 20.26 Billion | 21.42 Billion | 21.85 Billion |
Capital Expenditure | -141.14 Million | 40.08 Million | -281.07 Million | -40.08 Million | -184.82 Million | 34.97 Million |
Effect of forex changes on cash | -7.19 Million | 116.55 Million | 5.99 Million | -110.56 Million | -290.9 Million | -136.8 Million |
Net cash flow / Change in cash | -94.03 Million | - | -1.17 Billion | -6.35 Billion | 4.57 Billion | 127.72 Million |
Free Cash Flow | 68.36 Million | -6.26 Billion | 2.23 Billion | 26.4 Million | 5.35 Billion | 2.45 Billion |
BOD
RESONANCE
ISOP
ASHIMASYN
GGRP
TTEN3